Radiation Dose Escalation by Percutaneous Interstitial Brachytherapy in Locally Advanced Non-small Cell Lung Cancer

Management of locally advanced non-small cell lung cancer is associated with a poor overall survival using concurrent chemoradiotherapy. Therefore, newer approaches to treatment which enable dose escalation are warranted. Interstitial brachytherapy in lung is a new emerging concept with many distinc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Indian journal of chest diseases & allied sciences 2009-04, Vol.51 (2), p.103-106
Hauptverfasser:	SHARMA, D. N, BAHL, Amit, THULKAR, S, RATH, G. K, JOTHY BASU, K. S, BANSAL, A, JULKA, P. K
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Brachytherapy - methods Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - radiotherapy Chemotherapy, Adjuvant General aspects Humans Lung Neoplasms - drug therapy Lung Neoplasms - radiotherapy Male Medical sciences Middle Aged Pneumology Radiotherapy Dosage Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Management of locally advanced non-small cell lung cancer is associated with a poor overall survival using concurrent chemoradiotherapy. Therefore, newer approaches to treatment which enable dose escalation are warranted. Interstitial brachytherapy in lung is a new emerging concept with many distinct advantages. We report here a case of locally advanced non-small cell lung cancer with residual disease after conventional treatment. The patient was successfully treated using percutaneous interstitial brachytherapy and is disease-free at 18-month follow-up.
ISSN:	0377-9343